These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15928597)

  • 1. [FLIP--an enemy which might lose the battle against the specific inhibitors of translation].
    Pajak B; Orzechowski A
    Postepy Hig Med Dosw (Online); 2005; 59():140-9. PubMed ID: 15928597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V; Mitsiades CS; Kotoula V; Tseleni-Balafouta S; Ashkenazi A; Koutras DA; Mitsiades N
    Am J Pathol; 2002 Aug; 161(2):643-54. PubMed ID: 12163389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
    Schuchmann M; Schulze-Bergkamen H; Fleischer B; Schattenberg JM; Siebler J; Weinmann A; Teufel A; Wörns M; Fischer T; Strand S; Lohse AW; Galle PR
    Oncol Rep; 2006 Jan; 15(1):227-30. PubMed ID: 16328060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
    Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
    Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL-induced signalling and apoptosis.
    MacFarlane M
    Toxicol Lett; 2003 Apr; 139(2-3):89-97. PubMed ID: 12628743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
    MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
    Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis.
    Kim Y; Suh N; Sporn M; Reed JC
    J Biol Chem; 2002 Jun; 277(25):22320-9. PubMed ID: 11940602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of flice-inhibitory protein (FLIP) and NFkappaB is associated with death receptor-induced cell death in human aortic endothelial cells (HAECs).
    Okada Y; Kato M; Minakami H; Inoue Y; Morikawa A; Otsuki K; Kimura H
    Cytokine; 2001 Jul; 15(2):66-74. PubMed ID: 11500081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.
    Shin EC; Seong YR; Kim CH; Kim H; Ahn YS; Kim K; Kim SJ; Hong SS; Park JH
    Exp Mol Med; 2002 May; 34(2):114-22. PubMed ID: 12085986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
    Kerbauy DM; Lesnikov V; Abbasi N; Seal S; Scott B; Deeg HJ
    Blood; 2005 Dec; 106(12):3917-25. PubMed ID: 16105982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
    Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.
    Ricci MS; Jin Z; Dews M; Yu D; Thomas-Tikhonenko A; Dicker DT; El-Deiry WS
    Mol Cell Biol; 2004 Oct; 24(19):8541-55. PubMed ID: 15367674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
    Imamura R; Konaka K; Matsumoto N; Hasegawa M; Fukui M; Mukaida N; Kinoshita T; Suda T
    J Biol Chem; 2004 Nov; 279(45):46415-23. PubMed ID: 15337758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells.
    Griffith TS; Chin WA; Jackson GC; Lynch DH; Kubin MZ
    J Immunol; 1998 Sep; 161(6):2833-40. PubMed ID: 9743343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
    Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
    Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.